Blue Trust Inc’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Blue Trust Inc’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-249	Closed	-$7.46K	–	2651
2026 Q2	$7.46K	Buy	+249	New	+$7.07K	﹤0.01%	1936
2025 Q4	–	Sell	-10	Closed	-$346	–	2615
2025 Q3	$346	Hold	10	–	–	﹤0.01%	2467
2025 Q2	$280	Hold	10	–	–	﹤0.01%	2363
2025 Q1	$251	Hold	10	–	–	﹤0.01%	2409
2024 Q4	$275	Sell	10 -508	-98%	-$14.2K	﹤0.01%	2367
2024 Q3	$12.8K	Buy	518 +247	+91%	+$6.73K	﹤0.01%	2105
2024 Q2	$8.73K	Buy	+271	New	+$7.69K	﹤0.01%	1976
2024 Q1	–	Sell	-106	Closed	-$4K	–	2405
2023 Q4	$4K	Buy	+106	New	+$3.9K	﹤0.01%	1914
2023 Q3	–	Sell	-4	Closed	–	–	2132
2023 Q2	$0	Sell	4 -7	-64%	-$286	﹤0.01%	2222
2023 Q1	$0	Sell	11 -38	-78%	-$1.56K	﹤0.01%	2435
2022 Q4	$2K	Buy	49 +26	+113%	+$1.09K	﹤0.01%	1922
2022 Q3	$1K	Buy	+23	New	+$1.18K	﹤0.01%	1926

Other funds holding LKFT

Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return

MQS Management New York $171M AUM 3.86% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Blue Trust Inc's LKFT Position: Q3 2026 in Review

Blue Trust Inc sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026, closing a stake of 249 shares — an estimated $7.46K sold.

Blue Trust Inc first reported a position in LKFT in Q3 2022 and held it in 12 quarters. The position peaked at $12.8K in Q3 2024. 29 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

Blue Trust Inc reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2026 after selling out during the quarter.
Blue Trust Inc sold 249 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $7.46K.
Blue Trust Inc first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2022 and held it in 12 quarters.
Blue Trust Inc's Lakefront Biotherapeutics American Depositary Shares position peaked at $12.8K in Q3 2024.
29 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.